PROBELPHARMA
ActiveFrom the official registers: KBO 26 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
PROBELPHARMA has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €120,358 and a net result of -€3,556. Equity is shrinking by about 5.5% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-06
financial year 2025 · micro format
2025
30-09
financial year 2024 · micro format · 61 days late
2024
24-06
financial year 2023 · micro format
2023
05-07
financial year 2022 · micro format
2022
24-06
financial year 2021 · micro format
2021
02-07
financial year 2020 · full format
2020
04-09
financial year 2019 · full format · 35 days late
2019
31-12
Financial
Weakest financial yearnet -€22,940
Net result drops to -€22,940, the lowest in the series; recovery starts the following year.
07-06
financial year 2018 · full format
2018
13-06
financial year 2017 · full format
2017
10-06
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank